|
MechanismTop II inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date19 Dec 1979 |
100 Clinical Results associated with Qingyuan Pharmaceutical Peaks CR Ltd.
0 Patents (Medical) associated with Qingyuan Pharmaceutical Peaks CR Ltd.
100 Deals associated with Qingyuan Pharmaceutical Peaks CR Ltd.
100 Translational Medicine associated with Qingyuan Pharmaceutical Peaks CR Ltd.